Literature DB >> 32924526

Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.

Hannah Zhang1,2, Mélissa Léveillé1,3, Emilie Courty1,4, Aysim Gunes1,4, Bich N Nguyen5,6, Jennifer L Estall1,3,2,4.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a growing epidemic linked to metabolic disease. The first stage of NAFLD is characterized by lipid accumulation in hepatocytes, but this can progress into nonalcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC). Western diets, high in fats, sugars, and cholesterol, are linked to NAFLD development. Murine models are often used to study NAFLD; however, there remains debate on which diet-induced model best mimics both human disease progression and pathogenesis. In this study, we performed a side-by-side comparison of two popular diet models of murine NAFLD/NASH and associated HCC, a high-fat diet supplemented with 30% fructose water (HFHF) and a Western diet high in cholesterol (WDHC), and these were compared with a common grain-based chow diet (GBD). Mice on both experimental diets developed liver steatosis, and WDHC-fed mice had greater levels of hepatic inflammation and fibrosis than HFHF-fed mice. In contrast, HFHF-fed mice were more obese and developed more severe metabolic syndrome, with less pronounced liver disease. Despite these differences, WDHC-fed and HFHF-fed mice had similar tumor burdens in a model of diet-potentiated liver cancer. Response to diet and resulting phenotypes were generally similar between sexes, albeit delayed in females. This study shows that modest differences in diet can significantly uncouple glucose homeostasis and liver damage. In conclusion, long-term feeding of either HFHF or WDHC is a reliable method to induce NASH and diet-potentiated liver cancer in mice of both sexes; however, the choice of diet involves a trade-off between severity of metabolic syndrome and liver damage.

Entities:  

Keywords:  HCC; NAFLD; NASH; cholesterol; fructose

Year:  2020        PMID: 32924526     DOI: 10.1152/ajpendo.00321.2020

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  7 in total

1.  Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH.

Authors:  Shashi Bala; Michal Ganz; Mrigya Babuta; Yuan Zhuang; Timea Csak; Charles D Calenda; Gyongyi Szabo
Journal:  Lab Invest       Date:  2021-08-27       Impact factor: 5.502

Review 2.  Is Arsenic Exposure a Risk Factor for Metabolic Syndrome? A Review of the Potential Mechanisms.

Authors:  Pablo Pánico; Myrian Velasco; Ana María Salazar; Arturo Picones; Rosa Isela Ortiz-Huidobro; Gabriela Guerrero-Palomo; Manuel Eduardo Salgado-Bernabé; Patricia Ostrosky-Wegman; Marcia Hiriart
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

Review 3.  Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment.

Authors:  Bo Zhu; Siu-Lung Chan; Jack Li; Kathryn Li; Hao Wu; Kui Cui; Hong Chen
Journal:  Front Cardiovasc Med       Date:  2021-09-07

4.  Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models.

Authors:  Sridhar Radhakrishnan; Steven F Yeung; Jia-Yu Ke; Maísa M Antunes; Michael A Pellizzon
Journal:  Curr Dev Nutr       Date:  2021-11-13

5.  Preventive Effects of Ilex Cornuta Aqueous Extract on High-Fat Diet-Induced Fatty Liver of Mice.

Authors:  Meifang Liu; Haoxin Jia; Yang He; Yu Huan; Zhe Kong; Nuo Xu; Xiangju Cao; YueTong Duan; Zhaoliang Li; Luyuan Yang; Wen-Ping Wei; Lifang Wang; Li Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-07       Impact factor: 2.650

6.  Mitigation of MAFLD in High Fat-High Sucrose-Fructose Fed Mice by a Combination of Genistein Consumption and Exercise Training.

Authors:  Chaheyla R St Aubin; Amy L Fisher; Jose A Hernandez; Tom L Broderick; Layla Al-Nakkash
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-23       Impact factor: 3.249

7.  FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption.

Authors:  Bethan L Clifford; Leslie R Sedgeman; Kevin J Williams; Pauline Morand; Angela Cheng; Kelsey E Jarrett; Alvin P Chan; Madelaine C Brearley-Sholto; Annika Wahlström; Julianne W Ashby; William Barshop; James Wohlschlegel; Anna C Calkin; Yingying Liu; Anders Thorell; Peter J Meikle; Brian G Drew; Julia J Mack; Hanns-Ulrich Marschall; Elizabeth J Tarling; Peter A Edwards; Thomas Q de Aguiar Vallim
Journal:  Cell Metab       Date:  2021-07-15       Impact factor: 31.373

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.